10th Annual Forum Pathways to Access & Reimbursement

CI's forum brings together government, manufacturers, patients, and payers to discuss patients access to the right drugs and provide a clear view of Canada’s pharmaceutical landscape with a strong focus on evidence generation, value-based decision making, expedited pathways to access, and patient perspectives. This is an opportunity to meet face-to-face with market access and drug pricing strategists from top drug manufacturers, key government officials and both public and private payers.

2024 program features:

• Pharmaceutical Policy Power Panel: reflections and projections on the evolution of Canada’s pharmaceutical access environment to help you plan for 2025 and beyond
• Technology Use Cases for Pharma: practical applications for managing market access and drug negotiations
• Hypothetical Case Study and Breakout Discussion: opportunities to improve the drug to market process through patient inclusivity
• Working Group on how to advance the use of value-based agreements in Canada
  Speakers include CDA, INNESSS, PMPRB, Bayer, Roche, Biogen and more.